Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | 0.85% | 93.83 | 1.9% | $1163.93m | |
| BMY | Bristol-Myers Squibb Co. | 0.71% | 61.32 | 1.0% | $1017.19m | |
| JNJ | Johnson & Johnson | 0.37% | 147.27 | 0.7% | $1009.80m | |
| PFE | Pfizer Inc. | -0.22% | 35.93 | 0.9% | $970.99m | |
| MRK | Merck & Co., Inc. | 0.82% | 82.22 | 0.7% | $859.42m | |
| LLY | Eli Lilly & Co. | -1.02% | 149.17 | 1.1% | $531.64m | |
| AZN | AstraZeneca Plc | -0.04% | 53.85 | 1.2% | $283.65m | |
| NVS | Novartis AG | 0.93% | 85.91 | 0.2% | $152.29m | |
| GSK | GlaxoSmithKline Plc | 0.11% | 41.70 | 0.2% | $126.54m | |
| NVO | Novo Nordisk A/S | 0.23% | 64.49 | 0.1% | $83.99m | |
| SNY | Sanofi | 0.30% | 50.10 | 0.2% | $78.95m | |
| RGEN | Repligen Corp. | -1.28% | 120.26 | 7.1% | $68.99m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 1.08% | 68.14 | 0.0% | $52.90m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.49% | 126.30 | 3.4% | $37.91m | |
| TPTX | Turning Point Therapeutics, Inc. | 1.28% | 62.98 | 0.0% | $37.82m |
Company Profile
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, KPL-716, KPL-045, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.